GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,557,000 | -61.9% | 22,160 | -67.9% | 0.07% | -70.5% |
| Q3 2020 | $6,715,000 | -11.8% | 68,980 | +11.2% | 0.25% | -25.1% |
| Q2 2020 | $7,611,000 | +61.8% | 62,020 | +15.4% | 0.34% | +22.3% |
| Q1 2020 | $4,705,000 | -28.5% | 53,730 | -14.6% | 0.27% | +3.4% |
| Q4 2019 | $6,578,000 | -3.2% | 62,910 | +6.5% | 0.26% | -14.8% |
| Q3 2019 | $6,793,000 | -28.4% | 59,050 | +7.2% | 0.31% | -26.1% |
| Q2 2019 | $9,492,000 | +51.2% | 55,060 | +47.8% | 0.42% | +52.5% |
| Q1 2019 | $6,279,000 | +108.2% | 37,250 | +20.3% | 0.28% | +76.9% |
| Q4 2018 | $3,016,000 | -49.4% | 30,970 | -10.2% | 0.16% | -39.3% |
| Q3 2018 | $5,958,000 | +84.3% | 34,490 | +48.9% | 0.26% | +87.6% |
| Q2 2018 | $3,233,000 | – | 23,170 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |